How the OMB's Uniform Guidance revision reshapes federal grant-making—and what court rulings mean for durable policy change.
After federal courts struck down the administration's 2025 science policy changes for procedural flaws, the White House pivoted to a more durable strategy: embedding its priorities in the OMB Uniform Guidance, the rulebook that governs all federal grants. For public administrators, this shift from temporary executive actions to formal rulemaking is a textbook case of the "presidential administration" model, using regulatory infrastructure to lock in policy changes that survive legal challenges. The proposed rules would grant OMB and agency heads broad authority to direct research priorities, terminate grants without peer review, and override scientific advisory panels, concentrating power in political appointees. With an effective date of October 1, 2026, institutions face a compressed window to retool their grant compliance systems for a landscape where funding decisions may hinge as much on White House directives as on scientific merit. For those weighing how this fits into the broader arc of public service leadership in federal agencies, this episode offers a concrete case study in how administrative strategy adapts when executive orders fail in court. Practitioners with a foundation in public health and public administration policy will recognize the familiar tension between political direction and expert-driven governance that now defines federal research funding.
How does shifting from executive orders to formal rulemaking make federal science policy changes harder to challenge in court? For public administrators, understanding this strategic pivot is key to grasping the current overhaul's staying power.
The Trump administration's initial approach to reshaping science policy relied heavily on executive orders and agency directives. These actions, often implemented without public input, were quickly challenged in federal court under the Administrative Procedure Act (APA). Multiple rulings in 2025-2026 found that agencies had skipped required notice-and-comment periods or made arbitrary decisions without adequate justification. Judges repeatedly issued injunctions, citing violations of APA sections 553 and 706, effectively halting policies ranging from grant restrictions to methodological changes in statistical programs.
For public administrators, these court losses underscored a fundamental tension: unilateral executive moves could rapidly implement a policy agenda but often proved legally fragile. The rulings reinforced the importance of procedural integrity in rulemaking, a concept central to public policy making and MPA/MPP curricula alike.
Rather than continue to litigate each blocked initiative, the administration shifted toward formal rulemaking through the Office of Management and Budget (OMB). The centerpiece is the proposed revision to the Uniform Guidance, a set of regulations governing all federal financial assistance, including scientific research grants. By embedding changes within this established framework, the administration aims to create a more durable legal foundation.
Unlike executive orders, properly promulgated rules under the APA carry the force of law and are less susceptible to being overturned as "arbitrary and capricious." The current proposal was published for public comment, a step designed to satisfy procedural requirements and preempt future litigation. Observers note that even if opponents challenge the final rule, courts generally defer to agencies that have demonstrated thorough deliberation and public engagement.
This pivot illustrates the "presidential administration" model: a concerted effort to centralize control within the executive branch, bypassing decentralized agency expertise. For federal administration careers and civil service, it signals a shift in where power over research priorities and grant conditions resides, increasingly at the White House level.
The transition from executive actions to formal rulemaking is more than a legal tactic; it reshapes the balance of authority in federal science agencies. Public administrators must now navigate a landscape where OMB's proposed rules could grant the executive branch expanded discretion to direct research, terminate grants, and ignore external review processes. The earlier court losses serve as a case study in how procedural missteps can derail policy, and how a determined administration can learn from those setbacks to engineer more resilient change. Federal administration best practices frameworks are being stress-tested in exactly this environment.
For those working in research administration or grant management, the takeaway is clear: what may appear as a regulatory technicality is actually a deliberate strategy to lock in controversial policies for the long term.
The Office of Management and Budget's 412-page proposal to revise the Uniform Guidance contains far-reaching mechanisms that alter how federal grants are awarded, monitored, and terminated. Beyond the volume, the changes represent a structural shift in decision-making authority, from career scientists and peer reviewers to political appointees aligned with presidential priorities.
The most visible change introduces mandatory pre-issuance reviews by political appointees for research grants. Agency heads, or their designees, would gain the power to approve or deny applications before funds are obligated, effectively overriding the scientific merit scores produced by peer review panels. External peer review, long the gold standard for evaluating research quality, is explicitly sidelined; the proposal allows agencies to disregard reviewer input at will. This centralization of control means that a grant's alignment with the administration's ideology could matter more than its methodological rigor or potential public benefit.
Critics argue this undermines the independence that has made U.S. research a global benchmark. When grant decisions are filtered through a political lens, the result is a narrower range of inquiry, with controversial or novel topics facing steep uphill battles.
Equally disruptive is the expanded authority to terminate or modify grants that are already underway. Under the proposed rule, agencies would gain broad discretion to alter the terms of current awards, including funding amounts, scope, or duration, or cancel them entirely. This creates extraordinary uncertainty for multi-year research projects, many of which were budgeted and planned under prior policy assumptions. Researchers, university administrators, and grant administrators relying on these funds could find their work upended mid-stream, with little recourse.
The proposal frames this as a tool for ensuring accountability, but the practical effect is a chilling one: institutions may hesitate to pursue long-term studies if the rug can be pulled at the next political cycle.
The Uniform Guidance revision codifies a prohibition on funding for diversity, equity, and inclusion (DEI) initiatives, extending earlier executive actions into permanent regulatory language. More broadly, it introduces a new "presidential priorities" standard: all grants must demonstrably align with the current administration's stated policy goals. This transforms grants from vehicles for investigator-driven discovery into instruments of political execution. The shift relocates priority-setting from agency scientists and front-line program officers to political leadership in the White House, cementing a top-down model of research governance. This dynamic sits at the heart of ongoing debates about civil service reform and where substantive policy authority should reside.
While the scientific community has been the most vocal stakeholder, these changes apply to every federal contract and grant governed by the Uniform Guidance, from infrastructure and education to public health and law enforcement. That means administrators across all levels of government will encounter these new rules. The proposal's breadth makes it a landmark in the history of federal-state partnership and grant management, affecting how billions of dollars flow to states, localities, and non-profits.
The Office of Management and Budget's proposed changes to Uniform Guidance introduce several mechanisms that expand executive control over federal research funding. These changes, open for public comment, aim to take effect October 1, 2026.
The shift from ad-hoc executive orders to durable regulatory changes is now being felt unevenly across the federal research landscape, with some science agencies already moving to align their grant processes with the administration's priorities.
The boldest vision for reshaping NIH comes from the Project 2025 policy blueprint, co-authored in part by Russell Vought, who now serves as OMB Director. The plan calls for consolidating NIH's 27 institutes into fewer, more politically accountable structures, revising the peer review process to reduce deference to external scientific judgment, and tightening ethics and biosecurity oversight. As of mid-2026, these proposals have not been enacted as a single comprehensive reform.1 However, elements overlap with existing research security and foreign influence initiatives, and the Uniform Guidance proposal would give OMB new authority to terminate grants for reasons tied to agency priorities, effectively achieving some of the same control without congressional action.2 University research administrators note that NIH's grant review could become more centralized if the final rule allows agency officials to override study section scores.
NSF has taken the earliest and most concrete steps to align with the OMB proposal. In December 2025, the agency raised the equipment capitalization threshold in its grant policies from $5,000 to $10,000, effective for awards made on or after December 8, 2025.3 This change, posted through the NSF Proposal and Award Policies and Procedures Guide (PAPPG) Supplement, mirrors a provision in the OMB draft that doubles the threshold government-wide. While the equipment threshold adjustment may appear administrative, it signals NSF's willingness to preemptively adopt the administration's regulatory stance before the rule is finalized. Other Uniform Guidance changes, including expanded conflict-of-interest disclosures and mandatory E-Verify requirements for contractors, are likely to follow if the proposal takes effect in October 2026.4
EPA and DOE research programs, which fund critical work on climate resilience, pollution control, and clean energy technology, face potentially significant curtailment under the new framework. The proposed rule's language allowing agencies to "terminate awards for agency priorities" gives political appointees broad discretion to halt projects that do not align with the administration's agenda.2 While specific budget impacts for EPA and DOE remain uncertain as of mid-2026, the administration's prior attempts to slash EPA's science budget and redirect DOE's advanced research funding underscore the vulnerability of these agencies. Public administrators working in careers in public administration in environmental and energy policy should monitor the final Uniform Guidance rule closely, as it could institutionalize a degree of programmatic control that earlier executive orders, later struck down in court, failed to achieve. Understanding what public policy is and how it works helps practitioners recognize how formal rulemaking, rather than executive action alone, can entrench priorities across administrations.
The proposed OMB changes represent a fundamental rebalancing of power between political appointees and career experts in federal grant-making, with direct consequences for public administrators at every level of government.
The Uniform Guidance revisions strip long-standing discretion from career civil servants who manage the scientific merit review and grant award processes. Under the new rules, political appointees would gain the authority to veto grants before they are issued, even when those grants have been favorably reviewed by independent expert panels. This pre-issuance veto mechanism marks a departure from decades of norm where peer review results were rarely second-guessed. For program officers and grants administrators within agencies, the change effectively reclassifies their role from decision-maker to recommender, with final authority centralized in politically accountable (and politically appointed) leadership. The practical effect is a narrowing of the administrative space where scientific expertise, rather than political alignment, drives funding choices. Understanding the difference between public administration and public policy helps clarify why this boundary matters: administrators execute; they are not traditionally positioned to override expert-driven merit determinations.
For state and local public administrators who manage federal pass-through grants, the proposal introduces a new layer of compliance. Not only must they continue to meet existing financial and programmatic reporting requirements, they must also ensure that their activities align with presidential priorities and do not conflict with new prohibitions on diversity, equity, and inclusion initiatives. This creates an uncertain landscape: administrators may need to overhaul program designs, staffing plans, and outreach strategies to avoid running afoul of federal terms that are still being defined. The burden falls disproportionately on smaller jurisdictions and public agencies that lack dedicated grant compliance teams, potentially chilling innovation in public services that rely on federal research partnerships. University-local government MPA partnerships offer one model for building the capacity these agencies urgently need.
Natalie Aviles, a sociologist who has studied the administration's approach to the NIH, describes the strategy as "presidentialist": a deliberate effort to centralize executive control over processes that have traditionally been insulated from direct political influence. OMB, historically a budget and management office, is now positioned as a substantive policy gatekeeper for scientific research decisions. The proposed changes expand OMB's reach from ensuring fiscal responsibility to shaping which lines of inquiry receive federal support, a role that public administration scholars often associate with program-specific agencies. By embedding these changes in the Uniform Guidance, the administration seeks to institutionalize a durable capacity for political direction of research, one that outlasts court challenges to temporary executive orders.
At its heart, this overhaul forces public administrators to confront a classic governance dilemma: how to balance political accountability (the legitimate right of elected officials to set policy direction) with the need for scientific autonomy and expert-driven merit review. For MPA and MPP graduates working in federal, state, or nonprofit research administration, the challenge is no longer theoretical. They must now navigate a system where the rules of the game can shift based on presidential priorities, potentially undermining the predictability and objectivity that have made the U.S. research enterprise a global model. Professional development in public policy and administration has never been more critical for equipping practitioners to engage these shifting frameworks. The public comment period, open until shortly before the rules are set to take effect on October 1, 2026, offers a critical juncture for these professionals to weigh in on how the new framework should, or should not, reshape the relationship between politics and science.
More than 80,000 public comments were submitted on the proposed Uniform Guidance changes before the July 13, 2026 deadline,1 reflecting intense engagement from research institutions and professional associations. The comment period, open for 45 days after the May 29 proposal,2 drew responses from universities, scientific societies, and public administrators concerned about expanded OMB authority over grant-making.
The proposed rule is docketed as OMB-2026-0034 on regulations.gov.3 Although the comment window is now closed, the text remains publicly accessible, including all submitted comments. Agencies like NSF already began aligning their internal policies with the proposal, signaling that the final rule, expected September 1 and effective October 1, 2026,4 will likely incorporate many of these revisions.
During the open period, individual comments that cited specific sections of the proposal and explained concrete operational impacts carried more weight than form letters. For example, public administrators flagged provisions allowing termination of grants without traditional peer review, noting how this could destabilize multi-year research programs within their agencies. Comments referencing exact regulatory language (e.g., proposed changes to 2 CFR 200) demonstrated deeper engagement and were more likely to be addressed in the final rule. Understanding what public policy is and how formal rulemaking fits within it helps practitioners craft substantive, technically grounded comments.
Several organizations urged members to submit comments seeking substantial changes. The Association of American Universities (AAU), Association of Public and Land-grant Universities (APLU), and Council on Governmental Relations (COGR) jointly released an executive briefing highlighting problematic provisions.5 The International Economic Development Council (IEDC) and ocean sciences community also issued calls-to-action.6 Separately, Senator Susan Collins requested an extension of the deadline and withdrawal of certain provisions,1 while House members expressed concern about impacts on NIH-funded research.
With the comment window closed, public administrators can take four steps. First, thoroughly review the proposed changes relevant to your agency's grant-making procedures. Second, monitor final rule developments through professional networks and OMB announcements. Third, coordinate with staff on adapting internal processes to potential new requirements. Fourth, engage with associations like APSA or NASPAA to track legislative and judicial responses to the rule's implementation. For those weighing graduate study to deepen their policy expertise, considering NASPAA accreditation for MPA programs is a strong starting point for evaluating which programs prepare practitioners for exactly these kinds of regulatory challenges. Separately, the broader implications of this rulemaking episode connect directly to Trump health policy in the second term, particularly where NIH-funded biomedical research intersects with federal health priorities.
The OMB Uniform Guidance proposal is currently in the public comment period. Agencies and professional societies are mobilizing responses, with many urging members to submit detailed objections. Once the comment window closes, OMB must review and address substantive feedback before issuing a final rule. The administration's stated target is October 1, 2026, for the new rules to take effect. However, that timeline is ambitious. The volume and complexity of comments, combined with potential legal maneuvering, could push final publication into early 2027. Even without formal delays, agencies need time to adjust internal procedures, as NSF has already begun doing by aligning its grant policies with the draft.
Shifting from executive orders to formal rulemaking makes the policy harder to overturn, but it does not render it immune to judicial review. Critics argue the proposal exceeds OMB's statutory authority under the Information Quality Act and the Administrative Procedure Act. A central claim is that the new rules give OMB and political appointees unchecked discretion to terminate grants or disregard peer review, creating arbitrary and capricious agency action. Because the Uniform Guidance applies across all federal grant-making, a successful challenge could hinge on whether OMB adequately justified its expansive interpretation of presidential control over research. Courts have already struck down earlier Trump administration science policies for APA violations, setting a precedent that quick, under-explained rule changes are vulnerable.
If a future administration seeks to undo these changes, it cannot simply issue a new executive order. Because the revisions are embedded in the Code of Federal Regulations, full reversal requires its own notice-and-comment rulemaking cycle. That process typically takes 12 to 18 months and must survive the same procedural scrutiny. In the medium term, this locks in the current administration's approach to research governance, even beyond its tenure. For public administration certifications and career development purposes, the lesson is clear: durable policy change comes through the regulatory process, not solely through executive action. This transition from temporary directives to permanent rules marks a fundamental escalation in the presidential administration model.
Regardless of the final rule's fate, the proposal has already shifted expectations about OMB's role. The office has historically focused on budgetary and procedural review, not substantive research decisions. By asserting authority to override scientific peer review and redirect funding based on political priorities, OMB is signaling a permanent institutional realignment. Even if parts of the rule are struck down, the fact that an administration pursued this path publicly and systematically changes the bounds of acceptable debate. Future OMB directors may face pressure to justify their stewardship of grant-making in terms that acknowledge this episode. For students and professionals in federal civil service MPA and MPP careers, the current moment offers a case study in how administrative strategy evolves, how agencies resist or adapt, and how the regulatory process can be wielded to reshape entire sectors of government.
Understanding the Trump administration's science policy overhaul requires clear answers to key questions facing public administrators. Below, we address the most pressing concerns about the shift in federal research oversight, agency impacts, and practical steps for engagement.
